Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

View:
Post by Rarbar99 on Aug 17, 2021 1:32pm

It’s over.

Today's report was the final nail in the coffin.
 

Ever after the stock dropped 65% overnight, only 1 out of 40 insiders bought the dip, and he only bought around 10K shares at a price of $1.03 which is laughable considering he is the CEO..

In today's report, they made sure to bring up the fact that they're beginning to focus on their new projects/upcoming drugs. It's seems like they're trying to prolong this fiasco as long as possible, but they know otenproxesual is going to be a failed drug. Sucks but this is the reality.

Comment by Doccole on Aug 17, 2021 3:59pm
I don't think there is any good news on the horizon.  I am sure there will be future "strong cash" positions with raises.  How anyone can listen or trust anything Dan says is beyond me. sorry to everyone that lost here.  
Comment by 123ABC on Aug 17, 2021 4:06pm
Yup, Dan is a joke but what does he care, look at how much he's sold in the last two years.
Comment by WalkOverTheStrt on Aug 17, 2021 4:33pm
that's some incredible speculation / reaching before the analysis from the AME is out. So they need two months to review and come up with a conclusion. I'd rather have them take the time now than rush it.  They have for years been working on other drugs, and before this they stated they planned on 352 to dose humans in 2022 (corp presenation from July). Why is this all of a sudden bad ...more  
Comment by Rawrasaurus on Aug 17, 2021 5:00pm
Yeah the sentiment on this stock has really shifted when the information is inconclusive at best. I just want to see the final write up + results of the animal toxicology studies. Last time I check, h2s poisoning through inhalation can inihibt CYP450 activity, but oral ingestion at doses higher than we're using does not. I'll wait for the long term animal studies before drawing conclusions ...more  
Comment by Rarbar99 on Aug 17, 2021 5:37pm
It's not speculation. If the company knew this was all fudd and an overreaction, they would be eating up this dip along with many institutional buyers. But they're not. No one is. They know this is not an overreaction and they know it's going to go lower. It's really that simple.
Comment by Doccole on Aug 17, 2021 6:17pm
We are a couple years out of they pursue this drug.  They will have to determine the lowest dose, then go to a phase 2 and hope the secondary endpoints lineup.  
Comment by Amigo11 on Aug 17, 2021 5:07pm
Do you as stup*d as you write ?
Comment by Rawrasaurus on Aug 17, 2021 5:11pm
Pretty sure they're a paid basher. Seems Yukon, Duster, Rar may all be. There's posts on Yahoo finances, CEO.Ca and here under different handles that are essentially identical and use the same grammar/syntax as what they post here so i think they're being paid to alter stock sentiment to allow bigger funds to cover their shorts. If you saw the tape from yesterday, cannacord, Merril ...more  
Comment by Inthepez on Oct 09, 2021 10:43am
On August 17, ratbar posted what you see below. Yet all he does on his board is comment about me. That’s what happens when trigger an incel. The last 10 posts are all about me. Am I in your dreams too ratbar? Lmao keep in mind that this fud fairy also wants you to believe he owns shares and is “bullish” on this stock. I should add his account was made in August 12 2021 lmao!! Happy thanksgiving ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities